Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement

Nanette Santoro; Glenn D Braunstein; Cherie L Butts; Kathryn A Martin; Michael McDermott; JoAnn V Pinkerton

doi:10.1210/jc.2016-1271

Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement

J Clin Endocrinol Metab. 2016 Apr;101(4):1318-43. doi: 10.1210/jc.2016-1271.

Authors

Nanette Santoro¹, Glenn D Braunstein¹, Cherie L Butts¹, Kathryn A Martin¹, Michael McDermott¹, JoAnn V Pinkerton¹

Affiliation

¹ Departments of Obstetrics and Gynecology (N.S.) and Medicine (M.M.), University of Colorado School of Medicine, Aurora, Colorado 80045; Department of Medicine (G.D.B.), Cedars-Sinai Medical Center, Los Angeles, California 90048; Program Leadership (C.L.B.), Biogen, Cambridge, Massachusetts 02142; Department of Medicine (K.A.M.), Massachusetts General Hospital, Boston, Massachusetts 02114; and Department of Obstetrics and Gynecology (J.V.P.), Midlife Health, University of Virginia, Charlottesville, Virginia 22908.

PMID: 27032319
DOI: 10.1210/jc.2016-1271

Abstract

This Scientific Statement finds that there is no rationale for routine prescribing of unregulated, untested, and potentially harmful custom compounded bioidentical hormone therapies.

Publication types

Review

MeSH terms

Drug Compounding / standards*
Endocrinology*
Hormone Replacement Therapy / methods*
Hormone Replacement Therapy / standards*
Hormones / therapeutic use*
Humans
Practice Guidelines as Topic / standards*
Societies, Scientific
Women's Health

Substances

Hormones